These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 6821866
21. Sarcomas of the hand and foot: analysis of local control and functional result with combined modality therapy in extremity preservation. Johnstone PA, Wexler LH, Venzon DJ, Jacobson J, Yang JC, Horowitz ME, DeLaney TF. Int J Radiat Oncol Biol Phys; 1994 Jul 01; 29(4):735-45. PubMed ID: 8040019 [Abstract] [Full Text] [Related]
22. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity. Ferrari S, Mercuri M, Rosito P, Mancini A, Barbieri E, Longhi A, Rimondini S, Cesari M, Ruggieri P, Di Liddo M, Bacci G. J Chemother; 1998 Dec 01; 10(6):484-91. PubMed ID: 9876058 [Abstract] [Full Text] [Related]
23. The role of surgery and resection margins in the treatment of Ewing's sarcoma. Sluga M, Windhager R, Lang S, Heinzl H, Krepler P, Mittermayer F, Dominkus M, Zoubek A, Kotz R. Clin Orthop Relat Res; 2001 Nov 01; (392):394-9. PubMed ID: 11716413 [Abstract] [Full Text] [Related]
26. Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study. Evans RG, Nesbit ME, Gehan EA, Garnsey LA, Burgert O, Vietti TJ, Cangir A, Tefft M, Thomas P, Askin FB. J Clin Oncol; 1991 Jul 01; 9(7):1173-80. PubMed ID: 2045857 [Abstract] [Full Text] [Related]
30. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones. Evans R, Nesbit M, Askin F, Burgert O, Cangir A, Foulkes M, Gehan E, Gilula L, Kissane J, Makley J. Int J Radiat Oncol Biol Phys; 1985 Jan 01; 11(1):129-36. PubMed ID: 3881374 [Abstract] [Full Text] [Related]
32. The treatment of localized Ewing's sarcoma: the experience at the Istituto Ortopedico Rizzoli in 163 cases treated with and without adjuvant chemotherapy. Bacci G, Picci P, Gitelis S, Borghi A, Campanacci M. Cancer; 1982 Apr 15; 49(8):1561-70. PubMed ID: 7066862 [Abstract] [Full Text] [Related]
33. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner GU, Kotz R, Amann G, Dockhorn-Dworniczak B, Harms D, Müller-Weihrich S, Welte K, Kornhuber B, Janka-Schaub G, Göbel U, Treuner J, Voûte PA, Zoubek A, Gadner H, Jürgens H. J Clin Oncol; 2001 Mar 15; 19(6):1818-29. PubMed ID: 11251014 [Abstract] [Full Text] [Related]
34. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies. Bacci G, Picci P, Ferrari S, Mercuri M, Brach del Prever A, Rosito P, Barbieri E, Tienghi A, Forni C. Cancer; 1998 Mar 15; 82(6):1174-83. PubMed ID: 9506366 [Abstract] [Full Text] [Related]
35. Ewing's sarcoma: standard and experimental treatment options. Subbiah V, Anderson P, Lazar AJ, Burdett E, Raymond K, Ludwig JA. Curr Treat Options Oncol; 2009 Apr 15; 10(1-2):126-40. PubMed ID: 19533369 [Abstract] [Full Text] [Related]
38. Intergroup Ewing's Sarcoma Study: local control related to radiation dose, volume, and site of primary lesion in Ewing's sarcoma. Razek A, Perez CA, Tefft M, Nesbit M, Vietti T, Burgert EO, Kissane J, Pritchard DJ, Gehan EA. Cancer; 1980 Aug 01; 46(3):516-21. PubMed ID: 6772293 [Abstract] [Full Text] [Related]